l 778,123 has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heymach, JV; Johnson, BE | 1 |
Bernhard, EJ; DeLaney, TF; Deutsch, P; Hahn, SM; Haller, DG; Kiel, KD; McKenna, WG; Mohiuddin, M; Morrison, B; Muschel, RJ; Pramanik, B; Regine, W; Smith, D; Stevenson, JP; Tepper, J | 1 |
1 review(s) available for l 778,123 and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Farnesyl transferase inhibitors for patients with lung cancer.
Topics: Alkyl and Aryl Transferases; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Farnesyltranstransferase; Humans; Imidazoles; Lung Neoplasms; Quinolones; Signal Transduction; Treatment Outcome | 2004 |
1 trial(s) available for l 778,123 and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.
Topics: Adult; Aged; Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Nausea; Skin Diseases; Stomatitis; Treatment Outcome; Tumor Cells, Cultured; Vomiting | 2002 |